Glucose Monitoring After Liver Transplant and Transplant Outcomes
Studies blood sugar levels, tracked by sensor, in adults after liver transplant.
Plain-language title generated from the registry record
Registry title: Liver Transplant CGM
Key facts
- Where
- New York, United StatesSee the site
Where in United States
- Mount Sinai HospitalNew York, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Icahn School of Medicine at Mount Sinai
- Trial code
- NCT07216508
- Record updated
- 24 August 2026
- Original description
This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.Read full original descriptionShow less
Post-discharge Glycemic Control After Liver Transplant and Impact on Transplant Outcomes
This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.
Inclusion: inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL.
Exclusion: if discharge is anticipated to be >30 days post-transplant, or; if recent transplant also included a kidney or pancreas transplant; having a planned discharge to a rehabilitation or nursing facility,; a contraindication to sensor placement,.